This collection is approved conditional on the following terms:
1. The agency will clearly indicate that estimates yielded from this study are representative of adult males in selected counties physically able to give informed consent within the 24 hours of their arrest (the study is not nationally or regionally representative); and
2. Should the ADAM study be extended, the agency will meet with OIRA to discuss proposed sampling design in advance of providing notice in the Federal Register.
Inventory as of this Action
Requested
Previously Approved
05/31/2014
36 Months From Approved
05/31/2013
1,750
0
5,000
765
0
1,853
0
0
1,653,540
A purposive, non-probability sample of sentinel sights (not representative of the US as a whole or individual states or other areas that were not surveyed) that replicates the ADAM methodology in order to obtain data comparable to previously established trends in 5 of the prior ADAM sites. ADAM II implements one quarter of data collection in five sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use.
The number of sites were reduced to 5 and the number of quarters reduced to 1 due to budget limitations. To ensure sufficient samples were collected in the ramining sites to enable annual estimations, the number of weeks for data collection were increased from 2 to 3.
The annual cost burden was reduced to zero because it consisted of labor costs that were already accounted for in the Annual Time Burden (Hr) column.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.